𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis

✍ Scribed by Arlan H. Mintz; John Kestle; Michel P. Rathbone; Laurie Gaspar; Herman Hugenholtz; Barbara Fisher; Graeme Duncan; Peter Skingley; Gary Foster; Mark Levine


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
622 KB
Volume
78
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


BACKGROUND. Cerebral metastasis is a common oncologic problem that occurs in

15-3096 of cancer patients; approximately half such metastases are single. Previous retrospective studies and two randomized trials reported that the addition of surgical extirpation prior to radiation therapy increased survival, neurologic function, and quality of life compared with radiation alone in patients with a single brain metastasis.

Agency, Vancouver Centre (G. Duncan); Ontario Clinical Oncology Group (M. Levine and P. Skingley).


πŸ“œ SIMILAR VOLUMES


Prediction of survival in patients with
✍ Yvette M. van der Linden; Sander P. D. S. Dijkstra; Ernest J. A. Vonk; Corrie A. πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 210 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Adequate prediction of survival is important in deciding on treatment for patients with symptomatic spinal metastases. The authors reviewed 342 patients with painful spinal metastases without neurologic impairment who were treated conservatively within a large, prospectiv

A randomized clinical trial to compare t
✍ Haq Nawaz; Atif Abbas; Asif Sarfraz; Martin D. Slade; Lisa Calvocoressi; Dorothe πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 107 KB

## Abstract ## BACKGROUND Although hospitals attempt to minimize the use of restraints, certain cases require their application. For such patients, there is a need for novel, safe and more humane restraint systems. ## OBJECTIVE To assess the acceptability and efficacy of safe enclosures in agita

The addition of cisplatin to cyclophosph
✍ Thierry Urban; Claude Chastang; FranΓ§ois-Xavier Lebas; Jean-Paul Duhamel; Guy Ad πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

## BACKGROUND. To assess whether the addition of cisplatin (100 mg/m 2 administered intravenously on Day 1) to CDE (cyclophosphamide [1000 mg/m 2 on Day 1], doxorubicin [45 mg/m 2 on Day 1], and etoposide [150 mg/m 2 on Days 1 and 2] combination is useful in the treatment of patients with small cel